Grifols Diagnostic Solutions

Mar 22, 2021

Grifols Installs First-Ever DG Reader Net Analyzer in North America Grifols, Barcelona, Spain, announced its first-ever installation in North America of the DG Reader Net semiautomated analyzer, used to facilitate pretransfusion blood type compatibility testing. This platform is now running at ThedaCare Medical Center-Wild Rose in Wisconsin. Many small, specialized laboratories like ThedaCare Medical Center-Wild Rose work hard to offer high quality service in pre-transfusion testing with limited semi-automated solutions available to them, resulting in manual testing that could yield results more difficult to interpret or manage for record keeping and audits. Compact and simple, DG Reader Net automates the reading and interpretation of DG Gel cards, a method that determines the presence of certain antigens in red blood cells and is used to indicate blood type compatibility. As a standalone solution, the DG Reader Net analyzer offers laboratories computer-assisted reading and interpretation of immunohematology (IH) tests with automatic results uploading to the laboratory information system. When paired with other Grifols testing platforms, DG Reader Net allows networks to standardize IH testing no matter the facility size. Before the DG Reader Net was installed, care team members at ThedaCare Medical Center-Wild Rose had to read results and manually enter them into the system. Now, the DG Reader Net gives team members results in minutes, which is crucial for a Critical Access Hospital like ThedaCare Medical Center-Wild Rose where immediate responses for blood transfusions are needed. “When our lab teams draw blood from a patient, we run a series of tests on that blood, and screen for antibodies, antigens, as well as determine the blood type,” says Rebecca Schultz, blood bank key operator, ThedaCare Medical Center-Wild Rose. “The DG Reader Net analyzer reads those results and exports everything to one centralized system. We believe it has the ability to minimize the potential for error and, due to its efficiency, creates additional time for our team members to provide care to our patients.” “We’re proud to be able to implement a semiautomated, intuitive blood banking solution at ThedaCare, ultimately helping reduce the risk associated with manually entering results to the Laboratory Information System, thus increasing patient safety,” says James Martinec, director, North America Marketing, Grifols Diagnostic Solutions. For more information, visit  Grifols . Share: